Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Credit agrmnt [a] Appointed director Quarterly results CC transcript
|
ENDOLOGIX INC (ELGX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/02/2018 |
BW
| Endologix Reports First Quarter 2018 Financial Results |
04/03/2018 |
BW
| Endologix, Inc. to Announce First Quarter 2018 Financial Results on May 2, 2018 |
03/19/2018 |
BW
| Endologix Reports Positive Results from Global ENCORE Analysis with Polymer Endovascular Aneurysm Repair (EVAR) Using Ovation Abdominal Stent Graft Systems |
02/21/2018 |
BW
| Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results |
01/25/2018 |
BW
| Endologix, Inc. to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on February 21, 2018 |
11/07/2017 |
BW
| Endologix Reports Third Quarter 2017 Financial Results |
10/10/2017 |
BW
| Endologix, Inc. to Announce Third Quarter 2017 Financial Results on November 7, 2017 |
08/02/2017 |
BW
| Endologix Reports Second Quarter 2017 Financial Results |
07/12/2017 |
BW
| Endologix, Inc. to Announce Second Quarter 2017 Financial Results on August 2, 2017 |
06/03/2017 |
BW
| Endologix Presents Positive Two-Year Clinical Data from the Nellix® EVAS FORWARD IDE Trial |
05/17/2017 |
BW
| Endologix Provides an Update on the Nellix® Endovascular Aneurysm Sealing System U.S. Regulatory Status |
05/04/2017 |
BW
| Endologix Reports First Quarter 2017 Financial Results |
04/17/2017 |
BW
| Endologix, Inc. to Announce First Quarter 2017 Financial Results on May 4, 2017 |
|
|